UBS Maintains a 'Buy' on Momenta Pharmaceuticals (MNTA); Attractive Despite Upcoming Binary Events
Go back to UBS Maintains a 'Buy' on Momenta Pharmaceuticals (MNTA); Attractive Despite Upcoming Binary Events| Baxter International Inc. (NYSE: BAX) | Delayed: 26.73 -0.32 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.05 | 52 Week High | $50.16 | |||
| Open | $27.01 | 52 Week Low | $34.06 | |||
| Day High | $27.16 | P/E | 7.30 | |||
| Day Low | $26.60 | EPS | $3.66 | |||
| Volume | 4,957,167 | |||||
| Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) | Delayed: 52.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.48 | 52 Week High | $18.32 | |||
| Open | $39.17 | 52 Week Low | $7.86 | |||
| Day High | $52.48 | P/E | N/A | |||
| Day Low | $52.48 | EPS | $-2.13 | |||
| Volume | 147,551 | |||||
